Oxsight Crystal Banner overlay

OxSight releases new Crystal device

The smart glasses are designed to enhance the vision of people who have peripheral vision loss

28 Nov 2018 by Emily McCormick

UK-based technology start-up OxSight has launched a new pair of smart glasses that aim to enhance the vision of people with sight impairment.

The device, OxSight Crystal, is an updated version of OxSight Prism, which was introduced on the market earlier this year. The new version of the smart glasses has been produced following user feedback and is been designed to support day-to-day and long-term wear.

Speaking about the release of OxSight Crystal, CEO Rakesh Roshan, said: “We are thrilled to be launching our second product less than three years after OxSight was founded. The new smart glasses provide users with greater flexibility and comfort, whilst still providing the life-changing vision enhancements of our Prism device.”

“We have had an overwhelming reaction from our community of users and look forward to making the Crystal glasses available more widely,” he added.

Like OxSight Prism, OxSight Crystal glasses use image interpretation technology and algorithms to enhance the remaining sight of people with peripheral vision loss. OxSight Crystal has also been approved as a medical device and is available through a number of opticians across the UK, as well as through the company.

The glasses can increase the users' horizontal field of vision up to 68 degrees and add or remove shade for lower light sensitivity depending on light conditions. OxSight Crystal are the lightest low vision glasses available on the market.

Peripheral vision loss can be caused by a range of eye conditions such as glaucoma, diabetic retinopathy, retinitis pigmentosa, myopic degeneration, retinopathy of prematurity and a number of other degenerative eye diseases. It can make daily activities like reading street signs and identifying obstacles difficult.

Advertisement

Your comments

You must be logged in to join the discussion. Log in

Comments (0)